Perrigo Company, is the nations largest manufacturer of store brand over-the-counter (non-prescription) pharmaceutical products and also manufactures store brand nutritional products. Store brand products are sold by national and regional supermarket, drugstore and mass merchandise chains under their own labels and compete with nationally advertised brands. The Company's products include analgesics, cough and cold remedies, antacids, laxatives, feminine hygiene and smoking cessation products, and vitamins, nutritional supplements and nutritional drinks. Perrigo Company has a market cap of $3.7 billion; its shares were traded at around $40.14 with a P/E ratio of 18.8 and P/S ratio of 1.8. The dividend yield of Perrigo Company stocks is 0.6%. Perrigo Company had an annual average earning growth of 13.3% over the past 10 years.
PRGO is in the portfolios of Edward Owens of Vanguard Health Care Fund, John Keeley of Keeley Fund Management, Kenneth Fisher of Fisher Asset Management, LLC, NWQ Managers of NWQ Investment Management Co.
Insiders' Positions with PRGO
- Sell:: Director David T Gibbons sold 30,000 shares of PRGO stock on 11/24/2009 at the average price of 39.88, the price of the stock has increased by 0.65% since
- Sell:: Senior VP and CIO Thomas Farrington sold 1,658 shares of PRGO stock on 11/24/2009 at the average price of 39.89, the price of the stock has increased by 0.63% since
- Sell:: Sr VP & Chief Scientific Offic Jatin Shah sold 11,910 shares of PRGO stock on 11/17/2009 at the average price of 39.76, the price of the stock has increased by 0.96% since
- Sell:: Executive VP, General Counsel Todd W Kingma sold 17,360 shares of PRGO stock on 11/13/2009 at the average price of 39.96, the price of the stock has increased by 0.45% since
- Sell:: Executive VP U.S. Generics Sharon Kochan sold 2,913 shares of PRGO stock on 11/13/2009 at the average price of 40.18, the price of the stock has decreased by 0.1% since
Rate This Article: |
  |